Posts by: Vanessa Pataia

News

Maintenance therapy with AstraZeneca’s Lynparza (olaparib) extended survival by more than one year in women with BRCA-mutated relapsed ovarian cancer, whose tumors responded to platinum-based chemotherapy, final results from the ... Read more

April 8, 2020April 8, 2020

Partnership to Ensure Gene-modified Cell Therapies for Ovarian Cancer Trials

News

Senti Biosciences is working with RoosterBio to ensure a quality supply of its candidate gene-modified cell therapies for ovarian cancer and other solid tumors, with a goal of bringing them into clinical ... Read more

March 13, 2020March 23, 2020

CytoDyn Cleared to Start Phase 2 Basket Trial of Leronlimab for Multiple Solid Cancers

News

CytoDyn has been cleared by an institutional review board to start a Phase 2 trial testing its investigational therapy leronlimab (PRO 140) to treat about 22 different solid cancers, including ovarian ... Read more

March 9, 2020March 9, 2020

Viral Vector Reformulated for Ovarian Cancer CAR T-cell Therapy, Anixa Says

News

Anixa Biosciences and Moffitt Cancer Center have completed the development and validation of a new viral vector designed to improve the efficacy of their immunotherapy candidate for ovarian cancer, based ... Read more